Cash Flow Statement
Growth Metrics

Elevance Health (ELV) Short term Debt (2016 - 2025)

Elevance Health (ELV) has disclosed Short term Debt for 17 consecutive years, with $150.0 million as the latest value for Q4 2025.

  • Quarterly Short term Debt fell 90.9% to $150.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $150.0 million through Dec 2025, down 90.9% year-over-year, with the annual reading at $150.0 million for FY2025, 90.9% down from the prior year.
  • Short term Debt for Q4 2025 was $150.0 million at Elevance Health, down from $180.0 million in the prior quarter.
  • The five-year high for Short term Debt was $2.2 billion in Q3 2022, with the low at $150.0 million in Q4 2025.
  • Average Short term Debt over 5 years is $792.8 million, with a median of $275.0 million recorded in 2021.
  • The sharpest move saw Short term Debt skyrocketed 1184.57% in 2022, then crashed 90.9% in 2025.
  • Over 5 years, Short term Debt stood at $275.0 million in 2021, then skyrocketed by 445.45% to $1.5 billion in 2022, then tumbled by 85.0% to $225.0 million in 2023, then skyrocketed by 632.89% to $1.6 billion in 2024, then plummeted by 90.9% to $150.0 million in 2025.
  • According to Business Quant data, Short term Debt over the past three periods came in at $150.0 million, $180.0 million, and $1.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.